FDA Inspection 1307078 — Proesis Biologics Westmoreland LLC
The FDA completed an inspection of Proesis Biologics Westmoreland LLC on March 5, 2026 in Dallas, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 5, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Dallas, TX (United States)